Hims & Hers Health shares are trading lower after the company withdrew its weight-loss pill and after Novo Nordisk filed a lawsuit against the company for patent infringement. HHS General Counsel Mike Stuart posted on social media that it referred the company to the DOJ for investigation of potential violations.